Data representation by boxplots in the whole figure is the same as in Figure 1F . Examples for copy number plots derived from the 450k analyses showing a 22q loss, no detectable aberration on SMARCB1, focal deletions in and around the SMARCB1 locus or other focal aberrations on SMARCB1. (A) Heatmap derived from unsupervised clustering of 17 ATRT-WGBS cases using the 8,000 most variable CpG sites. Methylation data was derived from the WGBS dataset. (B) Boxplots indicating the methylation levels in different pediatric brain tumors, y-axis denotes the β values as derived from the 450k data, x-axis the respective tumor (sub)group. (C-E) Boxplots indicating the mean methylation level (β values) for the ATRT subgroups and other pediatric brain tumors at intergenic regions (C), intronic regions (D) and exonic regions (E). Methylation levels were derived from the WGBS data. (F) Table showing the percentage of the genome occupied by different, regulatory methylation elements (PMD, DMV, LMR) in ATRT subgroups and cerebellar controls based on the WGBS data. Data representation by boxplots in the whole figure is the same as in Figure 1F . Data representation by boxplots in the whole figure is the same as in Figure 1F . (D) Barplots showing the expression levels of MITF in the cell lines BT12 (red) and BT16 (blue) as derived from the gene expression arrays.
Supplemental Experimental Procedures
Whole genome DNA sequencing Library preparation and whole genome sequencing of tumor and matching normal DNA from peripheral blood was carried out as described previously (Jones et al., 2013) . Briefly, 1-5 µg of genomic DNA was fragmented to ~300 bp insert size using a Covaris device. Size selection was conducted by agarose gel excision. For Paired-end library preparation we used Illumina, Inc. v2 protocols. Sequencing was performed on HiSeq2000 machines at the German Cancer Research Center (DKFZ) Genomics and Proteomics Core Facility. Sequencing reads were mapped and aligned as described (Jones et al. 2012) . Briefly, we called variants using samtools and vcf tools on the tumor bam files. The called positions were looked up in the control bam file and the resulting raw calls were filtered using different annotations and criteria to create a set of high confidence somatic SNVs. Indels were called using the pipeline platypus (Rimmer et al., 2014) . All coordinates used in the analyses are based on human reference genome assembly hg19, GRCh37 (ncbi.nlm.nih.gov/assembly/2758/). Gene annotations are based on genecode annotation release 19 (gencodegenes.org/releases/19.html). Whole Genome Sequencing data have been deposited at the European Genome-phenome Archive, EGA Study Accession ID EGAS00001001297.
Identification of structural variants and filtering
Structural variants comprising deletions, duplications, inversions and translocations, as well as their genotypes, were identified using the paired-end based computational tool DELLY v0.5.9 (Rausch et al., 2012) . Variants were predicted independently for each tumor sample and for their corresponding germline sample. SVs with reciprocal overlaps of 50% and with breakpoint coordinates differing less than 500bp (insert size of paired-end libraries) were considered to be identical. Somatic variants were defined as those present in the tumor sample but not in the germline control. Additionally, the predicted somatic variants were filtered for occurring in less than 0.5% of a set of germline samples from healthy individuals belonging to the 1000 Genomes Project. A high-confident set of somatic variants was obtained by considering only those with a mapping quality higher than 20 and with a minimum number of supporting pairs of 3 or higher if the region had a coverage greater than 100x. Regions with a high number of breakpoints were identified by a sliding window approach. In brief, the genome was divided into overlapping 1 Mb windows with 100kb offset, and the number of breakpoints per window (for SVs ranging from 5kb to 10Mb) were counted. Gene annotation was performed by overlapping predicted SVs with the protein coding genes from Gencode v19. For this analysis only variants smaller than 5 Mb were considered. These gene annotations were used to identify potential fusion genes if the genes at the breakpoints were in the same strand.
RNA sequencing 25 sequencing libraries were prepared using the TruSeq RNA Sample Preparation Kit v2 (Illumina) following the manufacturer's instructions. Briefly, polyA RNA was purified from 1µg of total RNA, fragmented to a median insert length of 155 bp and converted to cDNA. Then end repair, adenylation of 3´ ends and ligation of adapters were performed followed by PCR amplification (12 cycles). The generated libraries were validated using Qubit (Invitrogen) and Agilent 2100 Bioanalyzer (Agilent Technologies). Libraries were sequenced on the Illumina HiSeq 2000 (2x101 bp paired-end) according to the manufacturer's protocol. RNA-seq data were analysed using STAR version 2.3.0e, supplying GENCODE (version 19) gene annotations (human genome assembly hs37d5). Uniquely mapping reads were obtained by setting outFilterMultimapNmax to 1, otherwise default parameters were used. Alignment files were coordinatesorted and indexed using samtools (version 0.1.18). Gene expression was quantified in rpkm using the qCount function of Bioconductor package quasR. Differential gene expression patterns across ATRT subgroups were identified using ANOVA and setting an FDR cutoff 5%. To determine the genes expressed in a subgroup-specific manner, a post-hoc test (using the glht function of R package multicomp) was performed. RNA sequencing data have been deposited at the European Genome-phenome Archive, EGA Study Accession ID EGAS00001001297.
Whole genome bisulfite sequencing
For preparation of whole genome bisulfite sequencing libraries of tumor DNA, 5 µg of DNA per sample was sheared. With the help of an E-Gel electrophoresis system, fragments with insert sizes of 200-250 bp were isolated and bisulfite converted (EZ DNA Methylation kit, Zymo research). Alignment of FASTQ files was performed as described previously (Hovestadt et al., 2014) . Unsupervised hierarchical clustering was performed using the 8,000 most variable CG sites (metrics: 1-Pearson) over all probes covered. For overall methylation levels, we calculated the average for all CG sites covered (n = 28,217,009) or for the CGs represented in the respective genomic bins (Promoter, Exons, Introns or Intergenic). DMVs, PMDs, and LMRs were called as described previously employing the same cut-off parameters (Hovestadt et al., 2014) . For the analyses of differential methylation elements, mean methylation over all CG sites included in the respective element was calculated. To identify differential PMDs and differentially methylated Promoters, we applied ANOVA and a generalized linear model (R-package glht) for post-hoc contrasts and used a cut-off of p value= 0.05 for the posthoc testing. We compared each of the ATRT subgroups versus the others and versus previously published cerebellar controls (Hovestadt et al., 2014) . Correction for multiple testing was applied using the Benjamini-Hochberg procedure, coordinates with a p value < 0.05 were considered as statistically significant. Whole Genome Bisulfite Sequencing data have been deposited at the European Genomephenome Archive, EGA Study Accession ID EGAS00001001297.
DNA methylation profiling by 450k array DNA methylation from 150 primary ATRTs was assessed using Illumina HumanMethylation450 BeadChip arrays at the German Cancer Research Center (DKFZ) Genomics and Proteomics Core Facility according to the manufacturer's instructions and as previously described (Sturm et al., 2012) . Raw data files generated by the iScan array scanner were read and preprocessed using the capabilities of the Bioconductor package minfi (Aryee et al., 2014) . With the minfi package the same preprocessing steps as in Illumina's Genomestudio software were performed. Additionally, a correction for batch effects was performed. Batch effects were estimated by fitting a linear model to the log 2 transformed intensity values of the methylated and unmethylated channel. After removing the component due to the batch effect the residuals were back transformed to intensity scale and methylation beta values were calculated as described in Illumina's protocols. All samples were checked for expected and unexpected genotype matches by pairwise correlation of the 65 genotyping probes on the 450k array. In addition, the following filtering criteria were applied: Removal of probes targeting the X and Y chromosomes (n = 11,551), removal of probes containing a single nucleotide polymorphism (dbSNP132 Common) within five base pairs of and including the targeted CpG-site (n = 24,536), and probes not mapping uniquely to the human reference genome (hg19) allowing for one mismatch (n = 9,993). Finally, 438,370 probes were kept for analysis. Generation of copy number profiles was carried out as described (Sturm et al., 2012) . Unsupervised hierarchical clustering was performed using the 10,000 most variable CG-probes over the whole cohort. Distance measure was euclidean for the CG-sites and 1-Pearson for the samples, average linkage. For consensus clustering, the R package ConsensusClusterPlus was used at the default settings. For assessment of overall methylation levels, beta values of all CG probes were averaged. Methylation data have been deposited at the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo) and are accessible under accession number GSE70460.
Gene expression analyses
Tumor samples for which RNA of sufficient quantity and quality was available (n = 49) were analyzed on the Affymetrix GeneChip Human Genome U133 Plus2.0 array at the Microarray Department of the University of Amsterdam, the Netherlands. Sample library preparation, hybridization, and quality control were performed according to protocols recommended by the manufacturer. The MAS5.0 algorithm of the GCOS program (Affymetrix Inc) was used for normalization of the expression data. Detection p values were assigned to each probe set using the MAS5.0 algorithm. Quality of the arrays was ensured by inspection of the beta-actin and GAPDH 5′-3′ ratios as well as the percentage of present calls generated by MAS5.0. Data was analyzed using R2 (http://R2.amc.nl) or TMEV software (Saeed et al., 2003) . Gene expression data have been deposited at the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo) and are accessible under accession number GSE70678.
Immunohistochemistry for tyrosinase
For tyrosinase (TYR) immunohistochemistry on FFPE sections, a mouse monoclonal antibody [clone T311 (Dako, Glostrup, Denmark)] was used at a concentration of 1:200 with boiling pretreatment at pH9 on an automated staining system (DAKO).
ChIP-sequencing
Chromatin Immunoprecipitations for H3K27Ac, BRD4, OTX2, and MITF was performed at ActiveMotif (Carlsbad, CA) using the following antibodies: 39133, lot7 ActiveMotif (H3K27Ac), A301-985A100-3, Bethyl laboratories (BRD4), 13497-1-AP, lot 1, ProteinTech (OTX2), 39789 lot1, ActiveMotif (MITF). Libraries were sequenced on Illumina Hiseq 2000 systems (single-end, read length: 50 bp) at the German Cancer Research Center (DKFZ) Genomics and Proteomics Core Facility according to the manufacturer's instructions. For data analysis we used BWA (version 0.5.10), duplicate reads were marked employing Picard MarkTools. Peak finding for H3K27Ac was performed using MACS (Zhang et al., 2008 ) with a p value threshold of 1e-9, and with other settings as default parameters. As a control or each H3K27Ac ChIP-seq sample, its matched genomic DNA was used as the background. BRD4, OTX2, and MITF peaks were called using the same settings. ChIP-sequencing data for H3K27Ac, BRD4, OTX2, and MITF data have been deposited at the European Genome-phenome Archive, EGA Study Accession ID EGAS00001001297.
Classification of ATRT enhancers
H3K27Ac peaks of ATRT samples were merged into a single coordinate file. Peaks which could not be identified in at least two ATRT samples and were completely contained in promoter regions (± 1kb TSS) were excluded from any further analysis. Resulting set of merged and filtered peaks was used as putative ATRT enhancers. H3K27Ac signal intensities at enhancers were calculated in rpkm. Enhancers with statistically significant differential H3K27Ac signal (as identified using ANOVA and a FDR cut-off of 5%) and having 1.5 (log2) fold change difference across any ATRT subgroup comparison were called as subgroup specific ATRT enhancers. The remaining of the enhancers were referred to as common enhancers. Subgroup specific enhancers were grouped into 4 clusters using k means, as "TYR","MYC","TYR_SHH high", and "SHH".
Comparison of ATRT H3K27Ac peaks with published H3K27Ac data
A combined H3K27Ac peak-dataset was generated using our ATRT data and Roadmap project (Roadmap Epigenomics et al., 2015) and ENCODE data. For the Roadmap project, H3K27Ac alignment files were downloaded and peak finding for individual samples was performed using MACS (Zhang et al., 2008) . For the ENCODE provided H3K27Ac data, existing peak files were downloaded from http://ftp.ebi.ac.uk/pub/databases/ensembl/encode/integration_data_jan2011/byDataType/peaks/jan2011/histone_macs/optimal/hub/.
To create single peak-sets both from Roadmap and ENCODE, individual peak files for both datasets were merged into single coordinate files and resulting peaks were overlapped with ATRT H3K27Ac peaks (with a minimum 50% overlap criteria).
Identification of enhancer target genes
For each differentially regulated enhancer, we identified the topology-associated domain (TAD) encompassing the respective peak. A correlation test (Spearman's rank correlation coefficient) for H3K27Ac enrichment of the enhancer and expression level of genes localized in the same TAD as the enhancer were performed. For this, only protein coding genes were considered. This procedure was repeated for every enhancer, p values obtained by correlation tests were corrected for multiple testing using the Bioconductor package "qvalue". Correlating enhancer-gene pairs with a FDR less than 10% were preserved. Gene whose expression best correlated with the H3K27Ac enrichment of the enhancer was referred as the target of the enhancer. We assigned the second best correlating gene as another potential target only if the correlation coefficients differed less than 0.1 for the best and second best correlating gene.
Super-enhancer calling and target genes of super-enhancers
Super-enhancers were called using the HOMER software (http://homer.salk.edu/homer/ngs/index.html) using findPeaks command with "-style super" option. To call super-enhancers for different subgroups, H3K27Ac data was combined in a subgroup specific manner (i.e using the samples that belong to the respective subgroup). To call super-enhancers for ATRT without subgroup definition, H3K27Ac data was combined for all ATRT samples. SEs called for different subgroups of ATRT were intersected with respective subgroupspecific enhancers. Overlapping SEs were then assigned to genes using prior subgroup-specific enhancer-gene target pairs.
Nucleosome free region identification
Nucleosome free regions (NFR) per subgroup were identified by first combining H3K27Ac data in a subgroup-wise manner and subsequently running HOMER software (http://homer.salk.edu/homer/ngs/index.html) using "findPeaks" command with the option "-nfr".
Enrichment of transcription factors at subgroup-specific enhancers ENCODE motifs were downloaded from http://compbio.mit.edu/encode-motifs/. Each motif was overlapped with the NFRs from each class of subgroup-specific enhancers. Contingency tables showing the number of NFRs overlapping and non-overlapping with the respective motif were created. Subsequently, Chi-squared test was applied to find the motifs significantly enriched in NFRs of subgroupspecific enhancers. P values were corrected for multiple testing (FDR < 0.01). Enrichment of each motif was quantified as the ratio between observed counts over expected counts. To illustrate enriched pathways among genes with subgroup specific enhancers, we used Cytoscape (v 3.0)
Linking subgroup-specific enhancer target genes with transcription factors Nucleosome free regions (NFR) identified for each subgroup were matched with subgroup-specific enhancers in the classes of "TYR", "SHH" and "MYC". The resulting sets of NFRs for each subgroup were intersected with transcription factor motifs having top 30th percentile enrichment scores in the respective subgroup-specific enhancers and at the same time being overexpressed in the same subgroup. This approach resulted in identification of 3-7 transcription factors for every subgroup. For each transcription factor the number of binding sites within NFRs was determined. NFRs which displayed a higher number of binding sites for the given TF were referred to as sites most likely occupied by the respective transcription factor. Then, transcription factors were connected to enhancer target genes by finding the enhancers which were assigned to genes and contained resulting set of "most likely occupied" NFRs. Transcription factor regulatory networks for each subgroup were visualized using the platform Gephi (v 0.8.2-beta), where transcription factors represented as "sources" and enhancer target genes represented as "targets".
Heatmaps representing ChIP-seq signal intensity around genomic regions
To quantify ChIP-seq signal intensities at regions of interest the profilesForRegions function was used as described (Hisano et al., 2013) . In brief, the read counts at each position within a region of interest were summed and averaged over 100 bp windows tiling the region. Resulting values were scaled to a range between 0-1. To create the plots ChIP-seq signal intensities were first averaged over the samples for which both DNA methylation and respective ChIP-seq data was available, and then signal intensities were collapsed into single values across all specific regions of a specific category. Regarding the display of H3K27Ac, OTX2 and MITF at TYR-specific enhancers, signal intensities were calculated and averaged for TYR samples. Where OTX2 and MITF signals are shown in heatmaps, the signal was averaged over the sap les dkfz_ATRT_14 and dkfz_ATRT_16 if not indicated otherwise.
Inference of MITF-targets
To derive MITF targets from our MITF ChIP-Seq data, we overlapped the MITF peaks with the identified TYR-specific enhancers. Size of node labels in increases with the number of TYR specific enhancers for a given gene that overlap with a MITF peak.
